BACKGROUND: Although the genetic load is high in early-onset Parkinson's disease, thorough investigation of the genetic diagnostic yield has yet to be established. The objectives of this study were to assess variants in known genes for PD and other movement disorders and to find new candidates in 50 patients with early-onset PD. METHODS: We searched for variants either within genes listed by the International Parkinson and Movement Disorder Society Task Force on Genetic Nomenclature or rare homozygous variants in novel candidate genes. Further, exome data from 1148 European PD patients (International Parkinson Disease Genomics Consortium) were used for association testing. RESULTS: Seven patients (14%) carried pathogenic or likely pathogenic variants in Parkin, PLA2G6, or GBA. In addition, rare missense variants in DNAJC13:p.R1830C and in PPM1K:p.Y352C were detected. SPG7:p.A510V and PPM1K:p.Y352C revealed significant association with PD risk (P < 0.05). CONCLUSIONS: Although we identified pathogenic variants in 14% of our early-onset PD patients, the majority remain unexplained, and novel candidates need to be validated independently to better further evaluate their role in PD.
BACKGROUND: Although the genetic load is high in early-onset Parkinson's disease, thorough investigation of the genetic diagnostic yield has yet to be established. The objectives of this study were to assess variants in known genes for PD and other movement disorders and to find new candidates in 50 patients with early-onset PD. METHODS: We searched for variants either within genes listed by the International Parkinson and Movement Disorder Society Task Force on Genetic Nomenclature or rare homozygous variants in novel candidate genes. Further, exome data from 1148 European PD patients (International Parkinson Disease Genomics Consortium) were used for association testing. RESULTS: Seven patients (14%) carried pathogenic or likely pathogenic variants in Parkin, PLA2G6, or GBA. In addition, rare missense variants in DNAJC13:p.R1830C and in PPM1K:p.Y352C were detected. SPG7:p.A510V and PPM1K:p.Y352C revealed significant association with PD risk (P < 0.05). CONCLUSIONS: Although we identified pathogenic variants in 14% of our early-onset PD patients, the majority remain unexplained, and novel candidates need to be validated independently to better further evaluate their role in PD.
Authors: Martin Kann; Helfried Jacobs; Kathrin Mohrmann; Kirsten Schumacher; Katja Hedrich; Jennifer Garrels; Karin Wiegers; Eberhard Schwinger; Peter P Pramstaller; Xandra O Breakefield; Laurie J Ozelius; Peter Vieregge; Christine Klein Journal: Ann Neurol Date: 2002-05 Impact factor: 10.422
Authors: Ari Siitonen; Michael A Nalls; Dena Hernández; J Raphael Gibbs; Jinhui Ding; Pauli Ylikotila; Connor Edsall; Andrew Singleton; Kari Majamaa Journal: Neurobiol Aging Date: 2017-02-02 Impact factor: 4.673
Authors: B Schormair; D Kemlink; B Mollenhauer; O Fiala; G Machetanz; J Roth; R Berutti; T M Strom; B Haslinger; C Trenkwalder; D Zahorakova; P Martasek; E Ruzicka; J Winkelmann Journal: Clin Genet Date: 2018-01-24 Impact factor: 4.438
Authors: Janice L Farlow; Laurie A Robak; Kurt Hetrick; Kevin Bowling; Eric Boerwinkle; Zeynep H Coban-Akdemir; Tomasz Gambin; Richard A Gibbs; Shen Gu; Preti Jain; Joseph Jankovic; Shalini Jhangiani; Kaveeta Kaw; Dongbing Lai; Hai Lin; Hua Ling; Yunlong Liu; James R Lupski; Donna Muzny; Paula Porter; Elizabeth Pugh; Janson White; Kimberly Doheny; Richard M Myers; Joshua M Shulman; Tatiana Foroud Journal: JAMA Neurol Date: 2016-01 Impact factor: 18.302
Authors: Cynthia Sandor; Frantisek Honti; Wilfried Haerty; Konrad Szewczyk-Krolikowski; Paul Tomlinson; Sam Evetts; Stephanie Millin; Thomas Keane; Shane A McCarthy; Richard Durbin; Kevin Talbot; Michele Hu; Caleb Webber; Chris P Ponting; Richard Wade-Martins Journal: Sci Rep Date: 2017-01-24 Impact factor: 4.379
Authors: Remya R Nair; Silvia Corrochano; Samanta Gasco; Charlotte Tibbit; David Thompson; Cheryl Maduro; Zeinab Ali; Pietro Fratta; Abraham Acevedo Arozena; Thomas J Cunningham; Elizabeth M C Fisher Journal: Mamm Genome Date: 2019-06-15 Impact factor: 2.957
Authors: Shaun Martin; Stefanie Smolders; Peter Vangheluwe; Christine Van Broeckhoven; Chris Van den Haute; Bavo Heeman; Sarah van Veen; David Crosiers; Igor Beletchi; Aline Verstraeten; Helena Gossye; Géraldine Gelders; Philippe Pals; Norin Nabil Hamouda; Sebastiaan Engelborghs; Jean-Jacques Martin; Jan Eggermont; Peter Paul De Deyn; Patrick Cras; Veerle Baekelandt Journal: Acta Neuropathol Date: 2020-03-14 Impact factor: 17.088